Endocrine and Metabolic Dysregulation in Laminitis: Role of Pituitary Dysfunction

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-12-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/9781119169239.CH16
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lamellar pathology in horses with pituitary pars intermedia dysfunction.

  2016cited by this paper
• Equine metabolic syndrome

  2015cited by this paper
• Insulin dysregulation.

  2014cited by this paper
• Distribution of insulin receptor and insulin-like growth factor-1 receptor in the digital laminae of mixed-breed ponies: an immunohistochemical study.

  2013cited by this paper
• Glucocorticoid therapy and the risk of equine laminitis

  2013cited by this paper
• Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses.

  2013cited by this paper
• A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis.

  2013cited by this paper
• Advanced glycation endproducts in horses with insulin-induced laminitis.

  2012cited by this paper
• Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value.

  2010cited by this paper
• Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease.

  2010cited by this paper
• Fecal egg counts after anthelmintic administration to aged horses and horses with pituitary pars intermedia dysfunction.

  2010cited by this paper
• Corticosteroid-associated laminitis.

  2010cited by this paper
• Efficacy of trilostane for the treatment of equine Cushing's syndrome.

  2010cited by this paper
• Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia.

  2009cited by this paper
• Extrapituitary and Pituitary Pathological Findings in Horses with Pituitary Pars Intermedia Dysfunction: A Retrospective Study

  2009cited by this paper
• Seasonal Changes in Circadian Peripheral Plasma Concentrations of Melatonin, Serotonin, Dopamine and Cortisol in Aged Horses with Cushing’s Disease under Natural Photoperiod

  2008cited by this paper
• Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction.

  2008cited by this paper
• Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.

  2007cited by this paper
• Agreement in histologic assessments of the pituitary pars intermedia in aged horses.

  2005cited by this paper
• Nitration and Increased α‐Synuclein Expression Associated With Dopaminergic Neurodegeneration In Equine Pituitary Pars Intermedia Dysfunction

  2005cited by this paper
• Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly.

  2004cited by this paper
• Endocrinopathic laminitis in the horse

  2004cited by this paper
• Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.

  2004cited by this paper
• Adrenocortical carcinoma in a donkey.

  2003cited by this paper
• Equine Cushing's disease.

  2002cited by this paper
• Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease).

  2002cited by this paper
• Glucocorticoids and laminitis in the horse.

  2002cited by this paper
• Pituitary-independent Cushing's syndrome in a horse.

  2001cited by this paper
• Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.

  1997cited by this paper
• Equine Cushing's disease

  1997cited by this paper
• Laboratory diagnosis of equine pituitary pars intermedia adenoma.

  1995cited by this paper
• Adrenocortical carcinoma in a 12-year-old mare

  1994cited by this paper
• Equine pituitary adenoma: a functional and morphological study.

  1993cited by this paper
• Immunocytochemical Demonstration of Proopiomelanocortin-derived Peptides in Pituitary Adenomas of the Pars Intermedia in Horses

  1990cited by this paper
• Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary.

  1988cited by this paper
• Equine Adrenocortical Carcinoma with Hypercalcemia

  1987cited by this paper
• Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin.

  1986cited by this paper
• Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.

  1982cited by this paper
• Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.

  1982cited by this paper
• Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.

  1982cited by this paper
• Corticosteroid-induced laminitis? Further observations on the isolated, perfused hoof

  1980cited by this paper
• beta-Endorphin stimulates corticosterone synthesis in isolated rat adrenal cells.

  1979cited by this paper
• A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.

  1979cited by this paper
• Corticosteroid-potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis.

  1979cited by this paper
• Zwischenzelladenom der Hypophyse mit «Cushing-ähnlicher» Symptomatologie beim Pferd

  1974cited by this paper
• Pars intermedia of the hypophysis of rats after early-postnatal lesions of the basal hypothalamus: quantitative and qualitative observations.

  1973cited by this paper

• The Gingiva of Horses With Pituitary Pars Intermedia Dysfunction: A Macroscopic Anatomical Evaluation

  2022cites this paper
• The feeding and management practices of Australian horse owners

  2018cites this paper